CARDAMYST

ETRIPAMIL · Milestone Pharmaceuticals USA, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CARDAMYST, covering 2025-12-12 to 2025-12-12. Get the full timeline:

Most recent: FDA Approved: CARDAMYST — Original Application (Milestone Pharmaceuticals USA, Inc.)